title: [Combination of improved sex therapy and sildenafil for erectile dysfunction in Uigur men: retrospective analysis of 2505 cases].
abstract: OBJECTIVE
  The sex therapy is not yet popularized at present. This study aimed to evaluate the effect of the combination of the improved sex therapy and oral sildenafil on erectile dysfunction (ED).
  
  
  METHODS
  A total of 3130 Uigur cases of ED received in Xinjiang Bogda Hospital were divided into a control group (n=625) and a trial group (n=2505), the former treated with oral sildenafil alone, and the latter by the combination of the improved genital therapy and sildenafil, both for 3 months and followed up at 6 and 12 months after the treatment. The therapeutic effects were evaluated and compared using IIEF-5.
  
  
  RESULTS
  The IIEF-5 scores of the control group were 12.80 +/- 3.76 and 18.10 +/- 2.61 before and after the treatment, and 17.35 +/- 2.73 and 16.64 +/- 2.63 at 6 and 12 months, respectively, while those of the trial group were 12.73 +/- 3.52 and 19.06 +/- 4.07 before and af- ter the treatment, and 19.86 +/- 2.42 and 20.47 +/- 2.38 at 6 and 12 months, respectively, with statistically significant differences either between pre- and post-treatment (P < 0.05) or between the control and trial groups at 6 and 12 months (P < 0.05).
  
  
  CONCLUSIONS
  The combination of the improved sex therapy and oral sildenafil is superior to sildenafil alone in the treatment of ED, and its efficacy is relatively stable at 12 months.
authors.affiliation: Department of Andrology, Xinjiang Bogda Hospital, Urumqi, Xinjiang 830001, China.
authors.forename: Mu-la-jiang
authors.initials: ML
authors.lastname: Ai
authors.forename: Er-ken
authors.initials: EK
authors.lastname: Ai
authors.forename: Er-ban
authors.initials: EB
authors.lastname: Ku
authors.forename: Mu-tu-la
authors.initials: MT
authors.lastname: Ni
authors.forename: Er-mai-mai-ti
authors.initials: EM
authors.lastname: Nu
authors.forename: Zhi-hua
authors.initials: ZH
authors.lastname: Cai
authors.forename: A
authors.initials: A
authors.lastname: Bu-du-wai-li
authors.forename: De-er
authors.initials: DE
authors.lastname: Ka
authors.forename: Ke-bai-er
authors.initials: KB
authors.lastname: Ai
authors.forename: Yi-er
authors.initials: YE
authors.lastname: Ta
authors.forename: Si-hai-ti
authors.initials: SH
authors.lastname: Ai
authors.forename: A
authors.initials: A
authors.lastname: Da-li
authors.forename: Qin
authors.initials: Q
authors.lastname: Xu
mesh_terms: D000328:Adult; D000368:Aged; D044466:Asian People; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D012189:Retrospective Studies; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate